The inpatient costs related to revascularization of lower extremity artery disease in terms of amputation and mortality rates

CONCLUSIONS: In mid-long-term period, the care costs are increased with OS; however, EV treatment significantly increases the medical supplies and total costs. The increase in cost is correlated with poor outcome. Although the comorbidities and risk factors of these patients lead the clinicians to perform more challenging endovascular approaches, in mid-long-term period, particularly failed endovascular procedures are not promising in terms of outcomes and costs. We consider that the best-fit therapy on time is cost-effective, life and extremity-saving either, by avoiding deleterious effects of severe ischemia, such as severe pain, tissue loss, and related major adverse cardiaovascular events.PMID:36749662 | DOI:10.1177/17085381231156216

Source: Vascular - February 7, 2023 Category: Surgery Authors: Gulen S Alptekin Sinan Erkul Engin Akgul Ahmet Cekirdekci Source Type: research